Oramed Pharmaceuticals ($ORMP) Insider Trading & Smart Money Activity

Oramed Pharmaceuticals Inc. · Latest filing Oct 1, 2026

Oramed Pharmaceuticals Inc. ($ORMP) has 2 insider trades on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($225.53K), net -$225.53K.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

2

Net insider $ (12 mo)

-$225.53K

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

0

ORMP insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	2 · $225.53K	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ORMP insider, congress, 13F and analyst activity

All Insiders

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 1, 2026	Insider	Hexter JoshuaCOO & CBO	Sell (Open-market sale) 10b5-1	30K sh	$135.33K						—
Oct 1, 2026	Insider	Gabay AvrahamChief Financial Officer	Sell (Open-market sale) 10b5-1	20K sh	$90.20K						—

1W / 1M / 6M = how ORMP moved from the trade or filing date.

Insider trading in ORMP: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Hexter Joshua	COO & CBO	1	-$135.33K		Oct 1, 2026
Gabay Avraham	Chief Financial Officer	1	-$90.20K		Oct 1, 2026

Frequently asked questions

Are ORMP insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $225.53K, a net -$225.53K.

What is the latest insider trade in ORMP?

Hexter Joshua, COO & CBO filed a sell (open-market sale) of 30K sh worth $135.33K on Oct 1, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.